Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects

Study Identifier
LAT-KOR-01
CT.gov Identifier
NCT01229423
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Hypotrichosis
    • Study Drug
  • bimatoprost 0.03%
    • Phase
    Phase 4
    Sex
    Female
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Eyelash prominence assessment of minimal or moderate * Of Korean ethnicity
    Exclusion Criteria:
    * Any eye disease or abnormality * Any ocular surgery or use of any eyelash extension or eyelash growth products within 3 months * Any permanent eyeliner within 5 years * Eyelash implants of any kind * Eyelash tint or dye application within 2 months * Use of any treatment that may affect hair growth within 6 months

    Protocol Summary

    This study will evaluate the safety and efficacy of LATISSE® (bimatoprost 0.03%) in the augmentation of eyelashes in Korean women.

    Study Locations

    Location
    Status
    Location
    Seoul, Republic of Korea
    Status
    Not applicable